Answers are grounded in this paper and cite their sources.
These findings demonstrate the efficacy of D-VCd over VCd in patients with newly diagnosed amyloid light chain amyloidosis across cardiac stages, thus supporting its use in patients with cardiac involvement. (NCT03201965).
No takes yet. Share an insight, caveat, or question.
Minnema et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: